99 related articles for article (PubMed ID: 23280017)
1. Altered expression of survivin, Fas and FasL contributed to cervical cancer development and metastasis.
Wu SF; Zhang JW; Qian WY; Yang YB; Liu Y; Dong Y; Zhang ZB; Zhu YP; Feng YJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2044-50. PubMed ID: 23280017
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
3. [Expression of survivin in ovarian epithelial carcinoma and its correlation with expression of Fas and FasL].
Ma XY; He FX; Wu SF; Lu YP; Ma D
Ai Zheng; 2004 Feb; 23(2):173-6. PubMed ID: 14960238
[TBL] [Abstract][Full Text] [Related]
4. Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues.
Li Y; Xu DF; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(9):11915-20. PubMed ID: 26617948
[TBL] [Abstract][Full Text] [Related]
5. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer.
Zhou JH; Chen HZ; Ye F; Lu WG; Xie X
Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
7. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
[TBL] [Abstract][Full Text] [Related]
9. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
[TBL] [Abstract][Full Text] [Related]
10. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
11. FasL:Fas ratio--a prognostic factor in breast carcinomas.
Reimer T; Herrnring C; Koczan D; Richter D; Gerber B; Kabelitz D; Friese K; Thiesen HJ
Cancer Res; 2000 Feb; 60(4):822-8. PubMed ID: 10706087
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
Munakata S; Watanabe O; Ohashi K; Morino H
Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
[TBL] [Abstract][Full Text] [Related]
14. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.
Zhou WQ; Sheng QY; Sheng YH; Hou WJ; Xu GX; Wu YM; Lu H
Eur J Gynaecol Oncol; 2015; 36(1):62-8. PubMed ID: 25872337
[TBL] [Abstract][Full Text] [Related]
15. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression.
Kase H; Aoki Y; Tanaka K
Gynecol Oncol; 2003 Jul; 90(1):70-4. PubMed ID: 12821344
[TBL] [Abstract][Full Text] [Related]
17. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
Das H; Koizumi T; Sugimoto T; Chakraborty S; Ichimura T; Hasegawa K; Nishimura R
Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
[TBL] [Abstract][Full Text] [Related]
20. Expression of PTEN and survivin in cervical cancer: promising biological markers for early diagnosis and prognostic evaluation.
Lu D; Qian J; Yin X; Xiao Q; Wang C; Zeng Y
Br J Biomed Sci; 2012; 69(4):143-6. PubMed ID: 23310986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]